(Q48829185)

English

Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis.

scientific article published in February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/19006186

Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/19006186

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/19006186

Christopher G. Goetz

3

object named as

Christopher G Goetz

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

Charles Warren Olanow

1

object named as

C Warren Olanow

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

Jeffrey H Kordower

6

object named as

Jeffrey H Kordower

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

author name string

Jean-Michel Gracies

2

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/19006186

Thomas Freeman

5

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/19006186

James Godbold

7

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/19006186

Jose A Obeso

8

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/19006186

language of work or name

0 references

publication date

1 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/19006186

Movement Disorders

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/19006186

24

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/19006186

3

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/19006186

336-343

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/19006186

Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Levodopa-induced diphasic dyskinesias improved by subcutaneous apomorphine

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Early morning off-medication dyskinesias, dystonia, and choreic subtypes.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Cell transplantation in Parkinson's disease: how can we make it work?

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Cell therapy in Parkinson's disease - stop or go?

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Neural transplantation for the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Statistical Methods in Medical Research

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Dyskinesia after fetal cell transplantation for parkinsonism: a PET study

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Fetal nigral transplantation as a therapy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Subcutaneous lisuride infusion in Parkinson's disease. Response to chronic administration in 34 patients

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Fetal grafting for Parkinson's disease: expression of immune markers in two patients with functional fetal nigral implants.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22208

21 January 2018

Identifiers

10.1002/MDS.22208

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/19006186

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/19006186

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48829185&oldid=1238681107"